跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21 条关于
“SYNGAP1”
全部
21
临床试验
4
药物
9
机构
0
资讯
8
11个月前
Gene Therapy Shows Promise for SYNGAP1-Related Brain Disorders in Preclinical Study
11个月前
CAMP4 Therapeutics Advances SYNGAP1 Gene Therapy Toward Clinical Testing with GLP Toxicology Studies
去年
CAMP4 Therapeutics Secures $100 Million Financing to Advance First-in-Class SYNGAP1 Treatment
去年
Stoke Therapeutics Advances Dravet Syndrome Treatment with Zorevunersen
去年
Neuren Pharmaceuticals Reports Record DAYBUE Royalties as Rett Syndrome Therapy Sales Exceed $100 Million Quarterly Milestone
3个月前
Texas Children's and Baylor Awarded Up to $17.25 Million to Join ARIA IMPACT Network for Autism Clinical Trials
10个月前
Stoke Therapeutics Advances Phase 3 Dravet Syndrome Trial with Strong Financial Position Through 2028
3个月前
Systemic Gene Therapy SynCav1 Shields Brain from TDP-43 Damage by Fortifying Neuronal Resilience